Steven Favaloro
Directeur Général chez Genezen Laboratories, Inc.
Profil
Mr. Steven J.
Favaloro is a President & Chief Executive Officer at Genezen Laboratories, Inc. and an Executive Advisor at Ampersand Management LLC.
Mr. Favaloro was previously employed as a Chief Financial Officer by Arbor Biotechnologies, Inc., a Chief Financial Officer by Arranta Bio Holdings LLC, and a Chief Financial Officer by Brammer Bio LLC.
He received his undergraduate degree from Boston College, a graduate degree from Wallace E Carroll School of Management and an MBA from Wallace E Carroll School of Management.
Postes actifs de Steven Favaloro
Sociétés | Poste | Début |
---|---|---|
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023. | Directeur Général | 13/03/2023 |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Consultant / Advisor | 01/03/2023 |
Anciens postes connus de Steven Favaloro
Sociétés | Poste | Fin |
---|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/03/2023 |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Directeur Financier/CFO | 01/02/2022 |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/09/2019 |
Formation de Steven Favaloro
Boston College | Undergraduate Degree |
Wallace E Carroll School of Management | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Health Technology |
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023. | Health Technology |